Advertisement

Pharmaceuticals

Senate committee turns 340B spotlight on drugmakers

Senate committee turns 340B spotlight on drugmakers

The Senate health committee took hospitals out of the 340B hot seat to focus on pharmaceutical companies. Lawmakers wanted to know how much drugmakers may be overcharging 340B hospitals for discounted drugs.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print